BFM
SOPH icon

Boothbay Fund Management’s SOPHiA GENETICS SOPH Stock Holding History

Boothbay Fund Management’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-57,843
Closed -$287K – 2260
2023
Q1 		$287K Buy
+57,843
New +$187K 0.01% 1529

Other funds holding SOPH

GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AWA
Alta Wealth Advisors Woburn, Massachusetts $308M AUM 27.87% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return

Boothbay Fund Management's SOPH Position: Q2 2023 in Review

Boothbay Fund Management sold out of SOPHiA GENETICS (SOPH) in Q2 2023, closing a stake of 57,843 shares — an estimated $287K sold.

Boothbay Fund Management first reported a position in SOPH in Q1 2023 and held it in 1 quarter. The position peaked at $287K in Q1 2023. 34 funds tracked by Wall St. Rank hold SOPH as of Q2 2023.

  • Boothbay Fund Management reported no remaining SOPHiA GENETICS position as of Q2 2023 after selling out during the quarter.
  • Boothbay Fund Management sold 57,843 SOPHiA GENETICS shares in Q2 2023, an estimated $287K.
  • Boothbay Fund Management first reported a position in SOPHiA GENETICS in Q1 2023 and held it in 1 quarter.
  • Boothbay Fund Management's SOPHiA GENETICS position peaked at $287K in Q1 2023.
  • 34 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2023.

Based on Boothbay Fund Management's 13F filing for Q2 2023, filed 14 Aug 2023.